Cite

    Foell, D. et al. (n.d.). AB1089 Investigation of the efficacy and safety of secukinumab treatment in juvenile idiopathic arthritis subtypes of juvenile psoriatic and enthesitis-related arthritis: design of a randomised, double-blind, placebo controlled, multicenter study. Annals of the rheumatic diseases. p. 1654. [Online].